/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
events get well response. Operating Results Overview Operating results in the separate financial statements of the Company for the three-month periods ended 31 March 2020 and 2019 are as follows: (Million
follows: S&P Syndicate PCL and subsidiaries operating performance for 2nd quarter Ending 30 Jun 2020 Revenue from Sales and Services In the second quarter of year 2019, the Company and subsidiaries
2019 in order to enhance corporate efficiency and growth resulting in favourable operating results by achieving 12% gross profit margin in Q1-2020. UWC determined to continuously improve its strategic
(October – December 2018) and clarification of the operating result change excess 20%. Dear Sirs, We gladly inform to report our 2nd quarter performance figure during October – December 2018, ending December
The Stock Exchange of Thailand The operating performance for three-month period end 30 September 2019 of Mahachai Hospital Public Company Limited compared to the prior year was increasing in net profit
POST 005/2020 25 February 2020 Subject Clarification on the operating results of the consolidated financial statements (audited) for the year-ended 31 December 2019 with percentage of changes
Ref U. SET 017/2017 7 August 2017 Subject: Summary of Operating Performance and Financial Status for Quarter 2/2017 To: President The Stock Exchange of Thailand U City Public Company Limited and its
049-E 1/2 RC 049/17 10 November 2017 Subj. : Report on the Company’s operating results for the third quarter of the year 2017 To : President of the Stock Exchange of Thailand The Board of Directors